Science
Mechanism of Action
This ingredient functions by binding to specific prostaglandin receptors present in hair follicles. This interaction extends the anagen (growth) phase of the hair cycle and promotes the enlargement of the dermal papilla, resulting in the development of longer and thicker hair. Additionally, it stimulates melanogenesis, contributing to increased hair pigmentation.
Research
Clinical Evidence
Medium confidence0.03%
Transparency
Dusting Analysis
Methyl Bimatoprost Acidate is a pharmacologically active substance, not a cosmetic elegance ingredient, and its efficacy is concentration-dependent, making 'dusting' inappropriate.
The Formula
Formulation
Stability
The parent compound, Bimatoprost, exhibits high solubility in ethyl and methyl alcohols, with slight solubility in water. Ophthalmic solutions containing Bimatoprost typically maintain stability within a pH range of 6.8-7.8 during shelf life, with some formulations specifying a pH of 7.3 ± 0.5. Certain Bimatoprost acid polymorphs can transition into an oil phase at temperatures above 22°C in nitromethane or 40°C in anisole.
Conflicts
- Contact lenses (should be removed before application and reinserted after 15 minutes to avoid absorption into lenses)
- Other topical ophthalmic agents (administration should be separated by at least 5 minutes)
- Benzalkonium chloride hypersensitivity (as it is a common preservative in formulations)
- Unintended skin contact (may induce undesired hair growth)
Safety
Safety Profile
Although listed in the European Commission's CosIng database as a hair conditioning agent, the Scientific Committee on Consumer Safety (SCCS) has raised substantial concerns regarding the safety of prostaglandin analogues, including Methyl Bimatoprost Acidate, when used in cosmetic products, particularly around the eyes. These compounds are potent pharmacologically active substances with the potential for effects even at very low concentrations. Several regulatory authorities have either advised against or prohibited their use in eyelash growth-promoting cosmetics. The CIR Expert Panel has acknowledged Methyl Bimatoprost Acidate in discussions concerning the review of prostaglandin analogues, noting that similar compounds like Bimatoprost are US FDA-approved prescription drugs (e.g., Latisse 0.03% ophthalmic solution) for eyelash hypotrichosis. Reported side effects associated with Bimatoprost include conjunctival hyperemia (eye redness), eye pruritus (itching), periocular skin hyperpigmentation, eye irritation, dry eye, eyelid erythema, and the potential for permanent darkening of the iris.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its demonstrated efficacy in promoting hair growth, Methyl Bimatoprost Acidate presents significant safety concerns and regulatory warnings, rendering its inclusion in cosmetic products highly discouraged due to the risk of adverse effects.
Related
Similar Ingredients
Finding similar ingredients…